Cytotoxic synergy between alisertib and carboplatin versus alisertib and irinotecan are inversely dependent on MGMT levels in glioblastoma cells. [electronic resource]
Producer: 20191211Description: 231-240 p. digitalISSN:- 1573-7373
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Azepines -- administration & dosage
- Carboplatin -- administration & dosage
- DNA Modification Methylases -- antagonists & inhibitors
- DNA Repair Enzymes -- antagonists & inhibitors
- Drug Synergism
- Glioblastoma -- drug therapy
- Humans
- Irinotecan -- administration & dosage
- Pyrimidines -- administration & dosage
- RNA, Small Interfering -- genetics
- Tumor Cells, Cultured
- Tumor Suppressor Proteins -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.